The Nordic EMBL Partnership Directors featured on EMBL.de
[2019-04-12] Leadership was not only changed at EMBL, when EMBL Director General Edith Heard succeeded Iain Mattaj in January 2019. Also the Nordic EMBL Partnership for Molecular Medicine welcomed new directors: Janna Saarela, became new director at NCMM, Mark Daly, started as new director at FIMM, and Oliver Billker succeeded Bernt Eric Uhlin in the directorship in October 2018. The leadership changes were a reason for EMBL to about on its largest partnership and discuss with the new directors about values of the Nordic collaboration.
(Photo: Massimo del Prete/EMBL, screen shot)
Read the article on EMBL.de (authors Annabel Darby and Plamena Markova)
Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the pathogenicity of C. albicans and promotes the development of better therapy approaches. Details about the study can be found in a report recently published in the journal MBio, a publication of the American Society of Microbiology.
2nd Arctic Meeting on Clinical Tuberculosis, Umeå!
[2018-12-08] Annabel Darby, Communication Officer for the Nordic EMBL Partnership for Molecular Medicine, interviewed Oliver Billker a few weeks ago. Read about his visions for MIMS, his research and life in Umeå.
2018 Fernström Prize awardee at Umeå University becomes Felipe Cava. His research group studies how bacteria can adapt the construction of the cell wall to different host environments, knowledge that may be important for the development of new antibiotics.
The bacterium Vibrio cholerae was discovered more than 150 years ago but remains as one of the main causes of bacterial infectious disease globally, especially in low-income nations where it occurs endemic, and outbreaks of cholera disease can lead to major epidemics.
Welcome to the 3rd MIMS/UCMR-Mini-Symposium of this year!
[2018-04-19] An international team of researchers led by professor Niklas Arnberg at Umeå University, shows that adenovirus binds to a specific type of carbohydrate that is overexpressed on certain types of cancer cells. The discovery opens up new opportunities for the development of virus-based cancer therapy. The study is published in the latest issue of the scientific journal "Proceedings of the National Academy of Sciences of USA", PNAS April 19, 2018.
Two ERC Advanced Grants which have recently been awarded by the European Research Council (ERC) have a close relation to MIMS.
